军事知识服务平台
乳酸代谢与乳酰化修饰在炎症性肠病发生发展中的作用
Role of lactate metabolism and lactylation in the pathogenesis and progression of inflammatory bowel disease
摘要 炎症性肠病(IBD)是由遗传易感、免疫失衡、肠道菌群紊乱和屏障损伤共同驱动的慢性复发性肠道炎症。近年来,乳酸已由传统糖酵解终产物转变为连接代谢重编程与表观遗传调控的重要信号分子。本文围绕IBD中乳酸生成与转运、乳酸信号功能、组蛋白及非组蛋白乳酰化的调控机制及其病理意义进行综述,并探讨靶向乳酸代谢-乳酰化轴用于诊断、疾病分层和治疗干预的潜在价值,以期为IBD的精准治疗提供理论依据。
Abstract:
Inflammatory bowel disease(IBD)is a chronic,relapsing inflammatory disorder of the intestine driven by the interplay of genetic susceptibility,immune dysregulation,gut microbial dysbiosis,and intestinal barrier dysfunction. In recent years,lactate has been increasingly recognized not merely as an end product of glycolysis,but as an important signaling metabolite linking metabolic reprogramming to epigenetic regulation. This review summarizes lactate production and transport,and signaling in IBD,as well as the regulatory mechanisms and pathological significance of histone and non-histone lactylation. It further discusses the potential value of targeting the lactate metabolism-lactylation axis for diagnosis,disease stratification,and therapeutic intervention,with the aim of providing a theoretical basis for precision management of IBD.